Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Revenue by Segment

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Biotechnology Division	75.31B	73.24B	86.38B	100.27B	76.17B
HealthCare Sector	1.86B	2.31B	3.26B	4.48B	4.48B
Inter Segment Sales	-72.97M	-134.02M	-70.92M	-42.16M	-112.26M
Total	77.09B	75.41B	89.57B	104.71B	80.54B

Data Source: S&P Global Market Intelligence Last updated: Aug 13, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 13, 2026

Data Sources Report a data error